163 related articles for article (PubMed ID: 9556661)
1. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
[TBL] [Abstract][Full Text] [Related]
2. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
3. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
Landels EC; Ellis IH; Bobrow M; Fensom AH
J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum hexosaminidase A in pregnancy: effects of gestational age and fetal genotype.
Ben-Yoseph Y; Pack BA; Thomas PM; Nadler HL; Kaback MM
Am J Med Genet; 1988 Apr; 29(4):891-9. PubMed ID: 2969680
[TBL] [Abstract][Full Text] [Related]
6. Use of 4-methylumbelliferyl-6-sulpho-2-acetamido-2-deoxy-beta- D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villi.
Grebner EE; Wenger DA
Prenat Diagn; 1987 Jul; 7(6):419-23. PubMed ID: 2958791
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
8. First trimester prenatal diagnosis of Tay-Sachs disease using the sulfated synthetic substrate for hexosaminidase A.
Callahan JW; Archibald A; Skomorowski MA; Shuman C; Clarke JT
Clin Biochem; 1990 Dec; 23(6):533-6. PubMed ID: 2149678
[TBL] [Abstract][Full Text] [Related]
9. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
10. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
Bayleran J; Hechtman P; Kolodny E; Kaback M
Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
[TBL] [Abstract][Full Text] [Related]
11. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
Buchalter MS; Wannmacher CM; Wajner M
J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
[TBL] [Abstract][Full Text] [Related]
12. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
13. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
Guetta E; Peleg L
Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
[TBL] [Abstract][Full Text] [Related]
15. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
17. Tay-Sachs disease: B1 variant.
Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
[TBL] [Abstract][Full Text] [Related]
18. Fetal hexosaminidase A in mother's serum: pitfalls for carrier detection and prospects for prenatal diagnoses of GM2 gangliosidoses.
Navon R; Lejbkowicz I; Adam A
Am J Hum Genet; 1987 Jan; 40(1):60-1. PubMed ID: 2949607
[No Abstract] [Full Text] [Related]
19. Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.
Ozkara HA; Sandhoff K
Brain Dev; 2003 Apr; 25(3):191-4. PubMed ID: 12689698
[TBL] [Abstract][Full Text] [Related]
20. Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.
Navon R; Nutman J; Kopel R; Gaber L; Gadoth N; Goldman B; Nitzan M
Am J Hum Genet; 1981 Nov; 33(6):907-15. PubMed ID: 6459736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]